Benefits of PSA Test for Prostate Cancer Substantially Greater than Generally Appreciated The benefits of the prostate-specific antigen (PSA) test to screen men for prostate cancer may be greater than the harm, say investigators at Weill Cornell Medicine, NewYork-Presbyterian, University of Washington School of Medicine and the Fred Hutchinson Cancer Research Center. While organizations such as the U.S. Preventative Services Task Force (USPSTF) and the American Academy of Family Physicians have been lukewarm or opposed to the routine use of the PSA test, in a commentary published in the New England Journal of Medicine, the investigators demonstrate that these recommendations …
A new type of test that uses complex sugars to detect prostate cancer earlier and with greater accuracy is being developed by researchers at the University of Birmingham. The test works by identifying sugars, known as glycans, in blood. These sugars are attached to protein molecules called PSA and are known to undergo distinct but subtle changes when cancer is present in the body. Read the article.
The PSA has allowed us to detect cancer at an earlier stage, and it has reduced the number of men with widespread metastasis from 40 per cent to less than five per cent. Too much ink and angst have been spilled in debating whether the PSA blood test should be used to screen for prostate cancer. Read the article.
Cochrane reviews are structured, systematic, focused reviews of evidence in the field of medicine that either support or do not support specific forms of diagnosis and management of patients with or suspected of having particular disorders. A newly published Cochrane review by Drost et al. has addressed the topic of “Prostate MRI, with or without MRI‐targeted biopsy, and systematic biopsy for detecting prostate cancer“, and had just been published by the Cochrane Library.
Prostate Cancer Canada is encouraging men to get tested for the potentially deadly disease with a bold campaign that references historical and fictional characters in the form of latex gloves – yes, those donned by doctors for the often dreaded digital rectal exam meant to detect the presence of tumours in the male sex gland. Read the article here.
January 2018 Awareness Night Transperineal Prostate Biopsies: a new paradigm in the diagnosis and monitoring of Prostate Cancer Dr. Stanley Flax MB, BCh, FRCSC Staff Urologist, North York General Hospital, Co-Chair, North York General Hospital’s OR Product Standardization & Evaluation Committee, Director, Gale & Graham Wright Prostate Cancer Centre. Dr. Adam Tunis MD, MSc, FRCPC Clinical Director of Medical Imaging Informatics, Staff Radiologist, North York General Hospital Dept. of Medical Imaging CLICK ON THE ARROW TO START THE VIDEO The Complete Presentation 36:22 minutes
A team of researchers from Cleveland Clinic, Louis Stokes Cleveland VA Medical Center, Kaiser Permanente Northwest, and other clinical sites have demonstrated that a new blood test known as IsoPSA detects prostate cancer more precisely than current tests in two crucial measures – distinguishing cancer from benign conditions, and identifying patients with high-risk disease. Read the article here.